EligibleTrials

Colchicine After Electrocardioversion for Atrial Fibrillation

Recruiting · NCT05890664 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Basel, Switzerland

View the official record on ClinicalTrials.gov →
Atrial Fibrillation

Interventions studied

ColchicinePlacebo

What this trial is about

The purpose of this study is to investigate whether a 3 month treatment course of low-dose Colchicine decreases the recurrence of Atrial fibrillation (AF) after electrocardioversion (ECV) in patients with AF.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

8 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.